Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Backgrounds And Aims: This study investigates the temporal patterns of occult cancer incidence among survivors of acute ischemic stroke (AIS), with a focus on variations by underlying stroke etiology.

Patients And Methods: We analyzed data from a prospective, multicenter stroke registry and a national claims database, identifying AIS patients hospitalized between 2011 and 2013. Patients were categorized by stroke etiology into two groups: unidentified stroke etiology (USE) and identified stroke etiology (ISE). We estimated the occult cancer incidence rates within both groups and the overall AIS cohort. Using Poisson regression, we evaluated variations in cancer incidence over time and by stroke etiology, adjusting for age, sex, and smoking status. We also compared the first-year cancer incidence rate in our cohort to the age-standardized incidence rate (ASIR) in the general Korean population.

Results: Among 9759 AIS patients (median follow-up: 4.4 years), 976 occult cancers were diagnosed in 569 patients (5.8%). The first month post-stroke exhibited the highest cancer incidence rates across all groups: 8.3 (overall AIS), 14.3 (USE), and 7.6 (ISE) per 1000 person-months, with rates decreasing rapidly thereafter and stabilizing after 12 months. Compared to beyond 36 months, the adjusted incidence rate ratios within 1 month were 7.1 for overall AIS, 17.6 for USE, and 6.8 for ISE. The heightened risk in the USE group, compared to the ISE group, was significant within 1 month but diminished thereafter. Relative to the general population, the ASIR in this cohort was 1.6 times higher, particularly among men and those in the USE category.

Conclusion: Occult cancer incidence is notably high in the early period following AIS, especially among patients with USE. These findings underscore the importance of vigilant cancer screening immediately after a stroke, especially for patients without a clear stroke etiology.Data access statement:Access to the linked data utilized in this research was restricted to authorized researchers and limited to a pre-defined period only. Therefore, it is not possible to guarantee access to the data after the completion of this study, even upon reasonable request.

Download full-text PDF

Source
http://dx.doi.org/10.1177/17474930251335615DOI Listing

Publication Analysis

Top Keywords

cancer incidence
28
stroke etiology
20
occult cancer
16
ais patients
12
incidence rate
12
stroke
11
incidence
9
temporal patterns
8
patterns occult
8
cancer
8

Similar Publications

Purpose: Despite its importance, little is known about the patterns and predictors of Survivorship Clinic attendance in head and neck cancer (HNC). We sought to determine the cumulative incidence of Survivorship Clinic attendance stratified by demographic, clinical, and socioeconomic factors, and to identify factors independently associated with attendance.

Methods: Our analysis population consisted of 2,252 patients diagnosed with primary HNC and seen at our institution's HNC Survivorship Clinic after completing treatment from 2016-2021.

View Article and Find Full Text PDF

Prostate cancer (PCa) is the second most lethal cancer in men in the US. African American (AA) men have twice the incidence and death rate of European American (EA) men. Advanced PCa shows increased expression and activity of the DNA damage/repair pathway enzyme, poly (ADP-ribose) polymerase 1 (PARP1).

View Article and Find Full Text PDF

Background And Objective: The apex-to-base transperineal (TP) prostate biopsy needle trajectory may better sample the anterior prostate than the transrectal approach. There is evidence that African American men are more likely to harbor anterior tumors, suggesting that TP biopsy would result in better detection in these men. We performed a secondary retrospective analysis of prospective randomized trial data to determine whether African American race is associated with anterior tumor location and better detection with TP biopsy.

View Article and Find Full Text PDF

Background: Recurrent venous thromboembolism (VTE) is a common complication in patients with cancer-associated VTE. Limited data are available on treatment, particularly in patients receiving direct oral anticoagulants (DOACs). We aimed to evaluate current management strategies and outcomes in patients with cancer and recurrent VTE during treatment with low-molecular-weight heparin (LMWH) or DOACs.

View Article and Find Full Text PDF

Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort.

Diabetes Metab

September 2025

Paris Diabetology Federation, Paris, France; Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Université Paris Cité, Paris, France; Department of Diabetology and Endocrinology, Bichat Hospital, AP-HP, Paris, France.

Aim: - To investigate the incidences of death and lower limb amputation (LLA) among patients hospitalized with a first diabetic foot ulcer and to identify the associated risk factors.

Methods: - We leveraged medical records from 08/2017 to 10/2023 in the clinical data warehouse of the Greater Paris Hospitals. The primary outcome was the cumulative incidence of death estimated at 12 months.

View Article and Find Full Text PDF